Quick exitLeave this site quickly

Medicines A–Z

Every medicine used in gender-affirming hormone therapy in Australia, plus the medicines commonly used alongside it — with an in-depth page for each: how it is used, what it costs, what is monitored, and where it sits for supply.

← Back to supply & shortages

Stock seen by patients

What people have reported seeing on pharmacy shelves, newest first and grouped by medicine. All patient sightings are unverified: they are reports from the public, not confirmed stock levels. Always ring the pharmacy before travelling. To have a report removed, use the feedback page (preferred) or email [email protected].

Share a sighting →

← Back to all medicines

Estradiol and norethisterone patches (Estalis and Estalis Sequi)

A patch that combines two hormones in one product — estradiol (an oestrogen) and norethisterone acetate (a progestogen) — changed twice a week. It is registered in Australia for menopausal hormone therapy in someone with a uterus, not for gender-affirming care, and the Australian position statement on transgender hormone therapy does not recommend routinely adding a progestogen to feminising treatment. This entry is background for someone who has already been prescribed it — it is not an argument against your prescriber's choice.

Estradiol + norethisterone acetate · sold as Estalis Continuous, Estalis Sequi

Available in Australia?AvailableTGA records checked 21 Nov 2026.See supply detail

What it is

Estalis and Estalis Sequi are brand names for a patch that delivers two hormones through the skin at once — estradiol, an oestrogen, and norethisterone acetate, a progestogen (a synthetic hormone related to progesterone)[2][3].

Both are registered in Australia for menopausal hormone therapy in someone who still has a uterus (womb). The progestogen's job in that setting is to stop the uterine lining (endometrium) building up unopposed under oestrogen, which over years can lead to overgrowth of the lining (endometrial hyperplasia) or cancer. An oestrogen-only patch like Estradot doesn't carry that particular risk for someone without a uterus, which is most people using a patch for feminising hormone therapy[2][3].

The product information says combined hormone therapy like Estalis should not be used after a hysterectomy (an operation to remove the womb): the progestogen is not needed, and it may increase the risk of breast cancer[8].

That's the key thing to know if you've been given this rather than a plain oestrogen patch: it is doing a job — protecting a uterus — that most people on feminising hormone therapy don't need done. The Australian position statement on the hormonal management of transgender and gender diverse adults is direct about the progestogen component itself: "despite anecdotal reports that progestins increase breast growth, no data support their use." It lists thrombosis (blood clots), bloating, nausea and weight gain as added risks and concludes that progestins "are not recommended" in feminising therapy[1]. Australia's 2026 standards of care add that progestogens are no longer standard practice in feminising hormone therapy and that, if one is used, micronised progesterone is generally preferred over synthetic progestins such as the one in this product[7].

None of that means the patch was prescribed in error. There are a few genuine reasons someone might end up on a combined patch instead of a plain oestrogen one. During the long-running shortage of oestrogen-only patches (Estradot and Estraderm MX), some pharmacists and prescribers used a combined patch as one of the few transdermal oestrogen options actually on the shelf, accepting the extra progestogen as a trade-off for staying on a patch rather than switching to tablets or gel. Some prescribers who are more used to writing for menopausal hormone therapy may reach for a familiar combined product out of habit, without separately weighing whether the progestogen is doing anything for that particular patient. And a small number of people — for instance some intersex or non-binary people who do have a uterus — may genuinely need the endometrial protection this product provides[1][2][3]. Worth raising with whoever prescribed it, rather than assuming either that it's wrong or that it's necessary.

Two versions exist. Estalis Continuous delivers the same combined dose of both hormones every day, with no scheduled bleed. Estalis Sequi delivers oestrogen alone for the first two weeks of each four-week cycle, then adds the progestogen for the second two weeks — a pattern designed to produce a monthly withdrawal bleed, the way a natural cycle does[2][3].

Gender-Affirming Medicines South Australia

Clear, referenced information on gender-affirming medicines in South Australia — hormones, blockers and everything that happens at the pharmacy — for our community, and the people who care for, prescribe and dispense them.

What do you need today?

Guides

  • ReferencedSources cited on every guide
  • Pharmacist-writtenBy a registered pharmacist in Adelaide
  • Kept currentSupply checked daily from TGA records; PBS prices monthly
  • PrivateNo cookies, no tracking, Quick exit

Looking for a prescriber?

The Trans Health SA directory lists GPs, clinics and services across South Australia. Your pharmacist can also tell you which local prescribers regularly prescribe gender-affirming hormones.

Supply & shortages

Which hormone therapy medicines are hard to get in Australia right now, and what it means for you.

No supply problems reported

    Pharmacy stock reports

    What registered pharmacists say is on their shelves right now, checked against the AHPRA register before publishing. The official data above tells you about Australia; this tells you about particular pharmacies.

    See all pharmacy stock reports   Pharmacists: post a report →

    Seen it in stock, or missed out?

    Reports from other patients about what their local pharmacy had on the shelf. This sits alongside the official data above until a verified pharmacy stock feed is in place.

    Anonymous. No account, no personal details, and please don't put a person's name in the note.

    If your medicine is affected

    Start with your pharmacist — they can check other suppliers, order it in, and for the oestrogen patches can often supply an approved alternative without a new prescription. Filling your script a few days early, rather than on the last day, gives everyone room to move.

    ← Back to supply & shortages

    Pharmacy stock reports

    Stock reports posted by registered pharmacists, newest first. Each pharmacist's registration number is checked against the AHPRA register before their first report is published; after that their reports appear straight away.

    Post a report

    For pharmacists, and pharmacy staff posting on a pharmacist's behalf. Your name, registration number and work email (if you give one) are stored, and only the author can see them. Your registration number is never shown. The pharmacy name, suburb, medicine, stock position and note are public. To correct or remove a report, use the feedback page (preferred) or email [email protected].

    Not for promoting your pharmacy: report stock facts only. By posting you confirm you are a registered pharmacist, or are posting with one's permission, and that the report is accurate at the time of posting. Reports expire after 14 days.

    Send feedback

    Spotted something wrong, out of date or missing? Tell us here. Every message is read, and corrections are made as quickly as possible. The form is the preferred way to reach us; if you cannot use it, email [email protected].

    Please do not include personal health details. Messages are stored privately and never shared, and no tracking cookies are used.